Belinda R. Avalos - Concepedia

Author

Belinda R. Avalos

Also Known As

B Avalos, B R Avalos, B.R. Avalos, BELINDA R. AVALOS, Belinda Avalos, Belinda R Avalos, Belinda R. Avalos, Belinda Rene Avalos, Li, Shimena

182

Publications

3.7K

Citations

H-Index

Concepts

All Affiliations

The Ohio State University Levine Cancer Institute The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute Cleveland Clinic Carolinas Healthcare System

About

Belinda R. Avalos is an author at The Ohio State University specializing in medicine, immunology, and hematology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	14	17	879
2	Natural Sciences	4	4	371
3	Health Sciences	3	3	40
4	Blood Transplantation	2	2	62
5	Biochemistry	1	1	164

Belinda R. Avalos

Publications

3.3K

Citations

H-Index

Page 1

	Year	Citations
Phase 3 study comparing methotrexate and tacrolimus with methotrexate and cyclosporine for prophylaxis of acute graft-versus-host disease after marrow transplantation from unrelated donors. Richard A. Nash, Joseph H. Antin, Chatchada Karanes, PubMed	2000	591
Phase III study comparing methotrexate and tacrolimus (prograf, FK506) with methotrexate and cyclosporine for graft-versus-host disease prophylaxis after HLA-identical sibling bone marrow transplantation. Voravit Ratanatharathorn, Richard A. Nash, Donna Przepiorka, PubMed	1998	568
Better leukemia-free and overall survival in AML in first remission following cyclophosphamide in combination with busulfan compared with TBI Edward A. Copelan, Betty K. Hamilton, Belinda R. Avalos, Blood	2013	182
Molecular characterization and expression analysis of leucine-rich alpha2-glycoprotein, a novel marker of granulocytic differentiation. Lynn O’Donnell, Lawrence J. Druhan, Belinda R. Avalos PubMed Novel MarkerImmunologyGlycobiologyPathologyGranulocytic Differentiation	2002	170
Molecular characterization and expression analysis of leucine-rich α2-glycoprotein, a novel marker of granulocytic differentiation Lynn O’Donnell, Lawrence J. Druhan, Belinda R. Avalos Journal of Leukocyte Biology Novel MarkerLymphocyte DevelopmentImmunologyGlycobiologyImmune Regulation	2002	164
Human natural killer cells produce abundant macrophage inflammatory protein-1 alpha in response to monocyte-derived cytokines. Eric M. Bluman, Kevin J. Bartynski, Belinda R. Avalos, Journal of Clinical Investigation InflammationCytokineMip-1 AlphaMonocyte-derived CytokinesMedicine	1996	145
Phosphatidylinositol 3′-Kinase and SH2-Containing Inositol Phosphatase (SHIP) Are Recruited by Distinct Positive and Negative Growth-Regulatory Domains in the Granulocyte Colony-Stimulating Factor Receptor Melissa Hunter, Belinda R. Avalos The Journal of Immunology	1998	110
Survival following allogeneic transplant in patients with myelofibrosis Krisstina Gowin, Karen K. Ballen, Kwang Woo Ahn, Blood Advances	2020	94
Treatment of chronic myeloid leukemia with allogeneic bone marrow transplantation after preparation with BuCy2 JC Biggs, Jeff Szer, Pamela Crilley, Blood	1992	89
Granulocyte colony-stimulating factor receptor mutations in severe congenital neutropenia transforming to acute myelogenous leukemia confer resistance to apoptosis and enhance cell survival Melissa Hunter, Belinda R. Avalos Blood	2000	89

Page 1